Seaport Therapeutics, Inc.
Research Seaport Therapeutics, Inc. (SPTX) on Bullrun: market cap USD 1.33B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSPTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.33B
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 25.41M
- Free cash flow-USD 20.17M
Valuation Snapshot
latest market cap is USD 1.33B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.33B | n/a | n/a | n/a |
About Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Seaport Therapeutics, Inc.'s market cap?
Seaport Therapeutics, Inc.'s market capitalization is USD 1.33B.
What does Seaport Therapeutics, Inc. do?
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety.